XGN
Exagen Inc
8.70$
+2.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.6% | +4.7% | +4.5% | -17.0% | +9.2% | +13.5% | +11.0% | +0.2% | -3.6% | +4.1% | +15.2% | – | |
| – | -1.6% | +3.5% | +3.3% | -8.0% | -6.3% | +23.1% | +6.8% | +5.3% | +3.6% | -4.4% | +8.8% | – | |
| – | +5.7% | +5.6% | +5.3% | -22.9% | +21.4% | +7.6% | +13.9% | -3.1% | -8.6% | +10.9% | +19.7% | – | |
| – | -23.1% | -1.6% | +11.3% | +25.6% | +11.8% | -22.5% | +15.5% | +16.7% | +1.6% | -11.6% | -8.2% | – | |
| – | +9.6% | -14.0% | -1.7% | -3.0% | +0.4% | +14.3% | +3.0% | -0.8% | +8.6% | -2.9% | +3.7% | – | |
| – | +4.0% | -12.7% | +0.4% | +0.0% | +1.9% | +5.3% | +4.3% | +1.2% | +7.6% | -4.0% | +2.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.6% | -3.0% | +2.0% | +0.4% | +0.2% | -3.2% | +106.2% | +17.3% | +0.8% | -4.7% | -5.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +6,812.1% | – | – | – | -31,366.7% | – | -97.3% | +1,200.0% | +176.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.